
    
      Chronic idiopathic itch accompanies low-grade skin inflammation. These inflammatory features
      are associated with cytokine production which signal through the common JAK1-STAT pathway. It
      is therefore theorized that a selective JAK1 inhibitor such as INCB039110 may provide relief
      of itch symptom.
    
  